Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe livedo vasculitis treated with potassium iodide.

Zeev Abraham1, Michael Rozenbaum, Elena Portnoy

  • 1Dermatology Clinic, Reish Polyclinic, Haifa, Israel.

Rheumatology International
|March 14, 2003
PubMed
Summary

Potassium iodide (KI) successfully treated severe livedo vasculitis (LV) in a young woman. This novel approach proved effective when other treatments like corticosteroids failed, marking a first in LV therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Natural History of Deficiency of Adenosine Deaminase 2 Vasculitis in a Large Cohort and Factors Associated With Disease-Related Damage.

The Journal of rheumatology·2026
Same author

Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and mortality risk in SSc: a real-world national cohort study.

Rheumatology (Oxford, England)·2025
Same author

Tumor Necrosis Factor Inhibitor Therapy in Polyarteritis Nodosa: Expanding Evidence From Systemic to Cutaneous Disease.

The Journal of rheumatology·2025
Same author

Leg edema in systemic sclerosis: uncovering fasciitis and myositis as key underlying causes.

Rheumatology (Oxford, England)·2025
Same author

Hand Performance Assessed by Functional Dexterity Test Correlates With Clinical Disease Activity but Remains Altered in Rheumatoid Arthritis Patients Achieving Treatment Goals: A Cross-Sectional Cohort Study.

Musculoskeletal care·2024
Same author

Neutrophil-to-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosis.

Rheumatology (Oxford, England)·2024

Area of Science:

  • Dermatology
  • Vascular Medicine
  • Pharmacology

Background:

  • Livedo vasculitis (LV) is a rare, potentially debilitating vascular disorder.
  • Standard treatments for LV, including corticosteroids, aspirin, and azathioprine, often yield suboptimal results.
  • Refractory cases of LV pose a significant clinical challenge.

Observation:

  • A young woman presented with severe, treatment-resistant livedo vasculitis.
  • Previous therapeutic regimens involving corticosteroids, low-dose aspirin, and azathioprine were ineffective.
  • The patient's condition persisted despite multiple combination therapies.

Findings:

  • Successful treatment of severe livedo vasculitis was achieved using potassium iodide (KI).
  • Potassium iodide demonstrated efficacy where conventional therapies had previously failed.

Related Experiment Videos

  • This represents the first reported instance of KI being used to treat livedo vasculitis.

    • Implications:

    • Potassium iodide may represent a novel therapeutic option for severe, refractory livedo vasculitis.
    • Further research into the mechanism of KI in treating LV is warranted.
    • This case highlights the potential for alternative treatments in rare dermatological conditions.